Elderly patients with non-small cell lung cancer (NSCLC): A community cancer center experience

被引：0
|
作者：
Adonizio, Christian S. [1 ,2 ]
Pope, Jane [1 ]
Frantz, Andrea [3 ]
机构：
[1] Hematol & Oncol Associates NE Penn, Dunmore, PA USA
[2] Commonwealth Med Coll, Scranton, PA USA
[3] Univ Penn, Philadelphia, PA 19104 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2009年 / 4卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S660 / S661
页数：2
相关论文
共 50 条
  • [41] Gemcitabine in Non-Small Cell Lung Cancer (NSCLC)
    Christian Manegold
    Petr Zatloukal
    Kurt Krejcy
    Johannes Blatter
    Investigational New Drugs, 2000, 18 : 29 - 42
  • [42] BRCAness in non-small cell lung cancer (NSCLC).
    Waqar, Saiama Naheed
    Devarakonda, Siddhartha H. K.
    Michel, Loren S.
    Maggi, Leonard B.
    Watson, Mark
    Guebert, Kalin
    Carpenter, Danielle
    Sleckman, Barry P.
    Govindan, Ramaswamy
    Morgensztern, Daniel
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [43] Eicosanoids in non-small cell lung cancer (NSCLC)
    Johnson, D. H.
    Horn, L.
    Zhao, Z.
    Milne, G.
    Morrow, J.
    Sandler, A.
    Shyr, Y.
    Carbone, D. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [44] Gemcitabine in non-small cell lung cancer (NSCLC)
    Manegold, C
    Zatloukal, P
    Krejcy, K
    Blatter, J
    INVESTIGATIONAL NEW DRUGS, 2000, 18 (01) : 29 - 42
  • [45] The BC Cancer Agency experience with gefitinib in advanced non-small cell lung cancer (NSCLC)
    Ho, C
    Murray, N
    Melosky, B
    Laskin, J
    Anderson, H
    Karim, RR
    Hamata, L
    Bebb, G
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 220S - 220S
  • [46] Compliance with oral topotecan in patients with non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC).
    Eckardt, J. R.
    Ramlau, R.
    Gervais, R.
    Shepherd, F.
    O'Brien, M.
    Ciuleanu, T.
    Dharan, B.
    Wissel, P.
    Ross, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 387S - 387S
  • [47] Outcome of active anti-cancer treatment in elderly patients with advanced non-small cell lung cancer: A single center experience
    Kim, Ji Hye
    Ryu, Min Sun
    Ryu, Yon Ju
    Lee, Jin Hwa
    Shim, Sung Shine
    Kim, Yookyung
    Chang, Jung Hyun
    THORACIC CANCER, 2014, 5 (02) : 133 - 138
  • [48] Real world experience with pembrolizumab and nivolumab for treatment of non-small cell lung cancer (NSCLC) in an Irish Regional Cancer Center
    Dennehy, Colum
    Mullally, Will
    Goggin, Caitriona
    Gleeson, Jack Patrick
    Greene, John Patrick
    Power, Derek Gerard
    O'Reilly, Seamus
    Collins, Dearbhaile Catherine
    O'Mahony, Deirdre
    Bambury, Richard Martin
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [49] Treatment tolerance and survival in elderly patients with stage IV non-small cell lung cancer (NSCLC)
    Gijtenbeek, Rolof G. P.
    Helfrich, Gea
    Venmans, Ben J. W.
    Ten Brinke, Anneke
    De Jong, Kim
    Van Geffen, Wouter H.
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [50] Impact of neutropenia on chemotherapy administration in elderly patients with advanced non-small cell lung cancer (NSCLC)
    Knopf, K. B.
    Lipscomb, J.
    Gillespie, T. W.
    Stokes, M. E.
    Muehlenbein, C. E.
    Faries, D.
    Marciniak, M. D.
    Motabar, S.
    Buesching, D. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345